Article
Vitamin D receptor gene polymorphisms, bioavailable 25-hydroxyvitamin D, and hepatocellular carcinoma survival.
Journal of the National Cancer Institute - 1 Oct 2024
Shu Jing, Zhang Mingjie, Dong Xiaocong, Long Jingan, Li Yunshan, Tan Peishan, He Tongtong, Giovannucci Edward L, Zhang Xuehong, Zhou Zhongguo, Xu Yanjun, Xu Xiaojun, Peng Tianyou, Lu Jialin, Chen Minshan, Zhu Huilian, Zhang Yaojun, Fang Aiping
Abstract excerpt
BACKGROUND: Little is known about the role of vitamin D receptor polymorphisms and their interaction with vitamin D status in hepatocellular carcinoma (HCC) prognosis. METHODS: We evaluated the association of TaqI, BsmI, Cdx-2, and ApaI polymorphisms, individually and in combination, with liver cancer-specific (LCSS) and overall survival (OS) among 967 patients with newly diagnosed HCC. Subsequently, we examined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
